Your browser doesn't support javascript.
loading
Mineralocorticoid receptor blockade enhances the antiproteinuric effect of an angiotensin II blocker through inhibiting podocyte injury in type 2 diabetic rats.
Nishiyama, Akira; Kobori, Hiroyuki; Konishi, Yoshio; Morikawa, Takashi; Maeda, Isseki; Okumura, Michiaki; Kishida, Masatsugu; Hamada, Masahiro; Nagai, Yukiko; Nakagawa, Toshitaka; Ohashi, Naro; Nakano, Daisuke; Hitomi, Hirofumi; Imanishi, Masahito.
Affiliation
  • Nishiyama A; Department of Pharmacology, Kagawa University Medical School, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793, Japan. akira@kms.ac.jp
J Pharmacol Exp Ther ; 332(3): 1072-80, 2010 Mar.
Article in En | MEDLINE | ID: mdl-19940106
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proteinuria / Angiotensin II Type 1 Receptor Blockers / Diabetes Mellitus, Type 2 / Mineralocorticoid Receptor Antagonists / Podocytes Type of study: Etiology_studies Limits: Animals Language: En Journal: J Pharmacol Exp Ther Year: 2010 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proteinuria / Angiotensin II Type 1 Receptor Blockers / Diabetes Mellitus, Type 2 / Mineralocorticoid Receptor Antagonists / Podocytes Type of study: Etiology_studies Limits: Animals Language: En Journal: J Pharmacol Exp Ther Year: 2010 Type: Article Affiliation country: Japan